At a glance
ClinicalIndex Comparison RecordN/ACompleted· 746 enrolled
Drug / intervention
Direct-to-pharmacy oral PrEP refill visitsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Implementation Project to Improve the Efficiency of PrEP Delivery in Public Health HIV Care Clinics in Kenya
In Brief
A clinical study evaluating Direct-to-pharmacy oral PrEP refill visits for HIV Prevention and 2 related conditions. Completed, enrolled 746 participants across 1 site.
Detailed Summary
This is a pilot facility-based direct-to-pharmacy PrEP refill delivery to streamline care pathway in Kenyan public health HIV facilities implementing PrEP. Data on up to 500 PrEP users will be evaluated to understand delivery efficiency and in-depth interview with users and delivery key informants will be conducted to identify barriers and facilitators of implementation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Prevention, HIV Preexposure Prophylaxis, Implementation
CountriesKenya
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMay 2020
First PostedJun 2020
Primary CompletionJun 2023
Study CompletionApr 2024
TodayJul 2026
First PostedJun 11, 2020
Enrollment StartMay 1, 2020
Primary CompletionJun 30, 2023
Study CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 6.1 years ago
Interventions
Direct-to-pharmacy oral PrEP refill visitsother
Programmatic direct-to-pharmacy oral PrEP refill visits supported with client HIV self-testing